7
Registered trials
2
Recruiting
6
Unique sponsors
17
Unique IMPs
0
Commercial trials
Drug classes (ATC)
B
Haematology (ATC B)
2
H
Endocrinology (ATC H)
1
C
Cardiology (ATC C)
2
—
ATC code not specified
1
N
Neurology/Psychiatry (ATC N)
1
V
Various (ATC V)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
13 substances
Benzodiazepine
2 substances
Corticosteroid
1 substance
Supportive / diluent
1 substance
Phase III:
5
Phase II:
1
Phase IV:
1
Phase III
5 trials-
EndedAssistance Publique Hopitaux De Paris AcademicARGIPRESSIN; HYDROCORTISONE
-
PendingCHRU De Nancy AcademicEPINEPHRINE BITARTRATE
-
Not authorisedOdense University Hospital AcademicEPINEPHRINE; ISOPRENALINE HYDROCHLORIDE
-
PendingOdense University Hospital AcademicIMP not specified
-
RecruitingUniversiteit Twente AcademicDIAZEPAM; ESKETAMINE; LACOSAMIDE; LEVETIRACETAM; LORAZEPAM; MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE; PROPOFOL; SODIUM VALPROATE
Phase II
1 trial-
RecruitingHopital Erasme AcademicMAGNESIUM CHLORIDE HEXAHYDRATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM ACETATE TRIHYDRATE, SODIUM GLUCONATE; SODIUM LACTATE
Phase IV
1 trial-
EndedAarhus University Hospital AcademicSODIUM CHLORIDE; SODIUM HYDROGEN CARBONATE
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Odense University Hospital | Academic | 2 | Phase III | 0 |
| Hopital Erasme | Academic | 1 | Phase II | 1 |
| Assistance Publique Hopitaux De Paris | Academic | 1 | Phase III | 0 |
| CHRU De Nancy | Academic | 1 | Phase III | 0 |
| Universiteit Twente | Academic | 1 | Phase III | 1 |
| Aarhus University Hospital | Academic | 1 | Phase IV | 0 |
New trials by year
2021
1
2023
1
2025
2